MedPath

Medical University of Vienna

Medical University of Vienna logo
🇦🇹Austria
Ownership
Private
Established
1365-01-01
Employees
1K
Market Cap
-
Website
http://www.meduniwien.ac.at

Detection of SpO2-oscillations of Low Ventilated Areas

Withdrawn
Conditions
Atelectasis
First Posted Date
2013-12-30
Last Posted Date
2023-03-23
Lead Sponsor
Medical University of Vienna
Registration Number
NCT02022969
Locations
🇦🇹

MUW/AKH, Vienna, Austria

Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations

Not Applicable
Conditions
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Familiar Hypocalcuric Hypercalcemia
Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
Healthy Volunteers
Interventions
Device: 1H/ 13C and 31P Magnetic Resonance Spectroscopy
Other: Meal Tolerance Test
Other: Hyperglycemic-hyperinsulinemic clamp
First Posted Date
2013-12-30
Last Posted Date
2017-03-23
Lead Sponsor
Medical University of Vienna
Target Recruit Count
90
Registration Number
NCT02023489
Locations
🇦🇹

Medical University Of Vienna, Department of Internal Medicine III, Vienna, Austria

Cerebral Microembolism During Hemodialysis

Completed
Conditions
Cerebral Embolism
Complication of Dialysis
Thrombus Due to Renal Dialysis Device, Implant, or Graft
Interventions
Device: Renal hemodialysis (Fresenius 2008K, Bad Homburg, Germany)
First Posted Date
2013-12-27
Last Posted Date
2016-03-04
Lead Sponsor
Medical University of Vienna
Target Recruit Count
40
Registration Number
NCT02021045
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Cerebral Microemboli in Venoarterial ECMO Patients

Completed
Conditions
Complication of Extracorporeal Membrane Oxygenation
Cerebral Microembolism
Cerebral Perfusion
Interventions
Device: Transcranial Doppler Ultrasound
First Posted Date
2013-12-25
Last Posted Date
2019-05-08
Lead Sponsor
Medical University of Vienna
Target Recruit Count
20
Registration Number
NCT02020759
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Late Acquired Malaposition and Different Polymers

Phase 4
Completed
Conditions
Late Acquired Stent Malaposition
Interventions
Procedure: Everolimus-Eluting Stent (EES)
Procedure: Zotarolimus-Eluting-Stent (ZES)
Procedure: Biolimus-Eluting-Stent (BES)
First Posted Date
2013-12-24
Last Posted Date
2013-12-30
Lead Sponsor
Medical University of Vienna
Target Recruit Count
69
Registration Number
NCT02018991
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Multiple-dose Pharmacokinetics of Doripenem During Continuous Venovenous Hemodiafiltration and Molecular Adsorbent Recirculating System in ICU Patients and During Hemodialysis in Longterm Hemodialysis Patients.

Phase 3
Completed
Conditions
Infections During Organ Replacement Therapy
Interventions
Other: Pharmacokinetic profiling
First Posted Date
2013-12-23
Last Posted Date
2014-03-28
Lead Sponsor
Medical University of Vienna
Target Recruit Count
24
Registration Number
NCT02018939
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Surgery Versus Sclerotherapy for Isolated Accessory Great Saphenous Vein Varicosis

Phase 4
Completed
Conditions
Varicose Veins
Interventions
Procedure: surgery
Drug: sclerotherapy with aethoxysclerol foam
First Posted Date
2013-12-13
Last Posted Date
2013-12-13
Lead Sponsor
Medical University of Vienna
Target Recruit Count
40
Registration Number
NCT02010723
Locations
🇦🇹

Medical University of Vienna, Department of General Dermatology, Vienna, Austria

Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients

Phase 3
Completed
Conditions
Infection During Hemodialysis
Interventions
Drug: Administration of Amoxicillin / clavulanic acid
Procedure: Blooddraws for pharmacokinetic profiling
First Posted Date
2013-12-11
Last Posted Date
2017-05-31
Lead Sponsor
Medical University of Vienna
Target Recruit Count
16
Registration Number
NCT02007603
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Multiple-dose Pharmacokinetics of Ceftaroline During Continuous and Intermittent Renal Replacement Therapy in Patients Requiring Renal Replacement Therapy

Phase 4
Conditions
Infection During Renal Replacement Therapy
Interventions
Other: Ceftaroline in CRRT
Other: Ceftaroline in IRRT
First Posted Date
2013-12-10
Last Posted Date
2022-04-14
Lead Sponsor
Medical University of Vienna
Target Recruit Count
25
Registration Number
NCT02007122
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Gas Transfer on ILA-Activve

Not Applicable
Conditions
Hypercapnia
Interventions
Device: Change of blood flow or sweep gas flow ( ILA Activve)
First Posted Date
2013-11-28
Last Posted Date
2013-11-28
Lead Sponsor
Medical University of Vienna
Target Recruit Count
10
Registration Number
NCT01997528
Locations
🇦🇹

Dept. of Medicine I, ICU, General Hospital of Vienna, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath